Cel Sci Corporation (CVM)

[pijoe]

The Fda part is interesting considering if it's 10 percent improvement upon soc how is it that fast track is not warranted when you are talking about in the neighborhood of 160,000 plus or minus new cases a year. Then extrapolate that on Multikine for the potential of other cancers. Now those other cancers are delayed on a life saving/prolonging treatment. So really it's screwing alot more than the head and neck cancer etc. To go on from that it makes you wonder how the fda views Multikine.